Dian Diagnostics GroupLtd Past Earnings Performance
Past criteria checks 0/6
Dian Diagnostics GroupLtd's earnings have been declining at an average annual rate of -12.9%, while the Healthcare industry saw earnings growing at 2% annually. Revenues have been growing at an average rate of 11.1% per year.
Key information
-12.9%
Earnings growth rate
-13.0%
EPS growth rate
| Healthcare Industry Growth | 7.0% |
| Revenue growth rate | 11.1% |
| Return on equity | 1.0% |
| Net Margin | -0.7% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Dian Diagnostics Group Co.,Ltd.'s (SZSE:300244) Shares Bounce 37% But Its Business Still Trails The Industry
Oct 04
Dian Diagnostics Group Co.,Ltd. (SZSE:300244) Looks Inexpensive But Perhaps Not Attractive Enough
Aug 20Returns On Capital Signal Tricky Times Ahead For Dian Diagnostics GroupLtd (SZSE:300244)
Jul 12Dian Diagnostics GroupLtd (SZSE:300244) Will Pay A Smaller Dividend Than Last Year
Jun 10Dian Diagnostics GroupLtd (SZSE:300244) Seems To Use Debt Quite Sensibly
May 24Dian Diagnostics Group Co.,Ltd. Just Missed Earnings - But Analysts Have Updated Their Models
Apr 30Investors Holding Back On Dian Diagnostics Group Co.,Ltd. (SZSE:300244)
Apr 22Revenue & Expenses Breakdown
How Dian Diagnostics GroupLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 12,374 | -93 | 2,563 | 337 |
| 30 Jun 24 | 12,785 | -74 | 2,590 | 370 |
| 31 Mar 24 | 13,150 | 170 | 2,623 | 405 |
| 31 Dec 23 | 13,408 | 307 | 2,676 | 433 |
| 30 Sep 23 | 14,945 | -463 | 2,660 | 475 |
| 30 Jun 23 | 16,371 | 8 | 2,777 | 565 |
| 31 Mar 23 | 18,865 | 841 | 2,913 | 623 |
| 01 Jan 23 | 20,282 | 1,434 | 3,122 | 638 |
| 30 Sep 22 | 19,374 | 2,358 | 3,233 | 626 |
| 30 Jun 22 | 18,045 | 2,316 | 3,068 | 547 |
| 31 Mar 22 | 14,863 | 1,578 | 2,675 | 464 |
| 01 Jan 22 | 13,083 | 1,163 | 2,387 | 425 |
| 30 Sep 21 | 12,515 | 1,136 | 2,089 | 402 |
| 30 Jun 21 | 11,967 | 1,029 | 1,990 | 359 |
| 31 Mar 21 | 11,985 | 1,135 | 1,973 | 348 |
| 31 Dec 20 | 10,649 | 803 | 1,795 | 319 |
| 30 Sep 20 | 9,716 | 895 | 1,584 | 260 |
| 30 Jun 20 | 8,932 | 601 | 1,516 | 241 |
| 31 Mar 20 | 8,150 | 281 | 1,441 | 220 |
| 31 Dec 19 | 8,453 | 347 | 1,451 | 212 |
| 30 Sep 19 | 8,291 | 448 | 1,507 | 200 |
| 30 Jun 19 | 8,006 | 433 | 1,476 | 190 |
| 31 Mar 19 | 7,593 | 398 | 1,404 | 172 |
| 31 Dec 18 | 6,967 | 389 | 1,288 | 166 |
| 30 Sep 18 | 6,214 | 392 | 1,182 | 147 |
| 30 Jun 18 | 5,640 | 373 | 1,006 | 198 |
| 31 Mar 18 | 5,169 | 356 | 971 | 160 |
| 31 Dec 17 | 5,004 | 350 | 979 | 127 |
| 30 Sep 17 | 4,903 | 325 | 918 | 98 |
| 30 Jun 17 | 4,515 | 308 | 917 | 0 |
| 31 Mar 17 | 4,233 | 279 | 862 | 0 |
| 31 Dec 16 | 3,824 | 263 | 777 | 0 |
| 30 Sep 16 | 3,147 | 238 | 637 | 0 |
| 30 Jun 16 | 2,673 | 221 | 558 | 0 |
| 31 Mar 16 | 2,165 | 188 | 478 | 0 |
| 31 Dec 15 | 1,858 | 175 | 430 | 0 |
| 30 Sep 15 | 1,645 | 161 | 406 | 0 |
| 30 Jun 15 | 1,523 | 151 | 384 | 0 |
| 31 Mar 15 | 1,411 | 132 | 359 | 0 |
| 31 Dec 14 | 1,335 | 125 | 340 | 0 |
| 30 Sep 14 | 1,275 | 113 | 317 | 0 |
| 30 Jun 14 | 1,178 | 103 | 301 | 0 |
| 31 Mar 14 | 1,082 | 90 | 285 | 0 |
| 31 Dec 13 | 1,015 | 86 | 268 | 0 |
Quality Earnings: 300244 is currently unprofitable.
Growing Profit Margin: 300244 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300244 is unprofitable, and losses have increased over the past 5 years at a rate of 12.9% per year.
Accelerating Growth: Unable to compare 300244's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 300244 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-5.7%).
Return on Equity
High ROE: 300244 has a negative Return on Equity (0.98%), as it is currently unprofitable.